Shaanxi HuiKang Bio-tech Co., Ltd., established in 2001, focuses on the frontier areas of biotechnology-active protein and peptides, bio-regeneration engineering and applied science and technology research. With research technicians accounting for more than 37%, HuiKang is a biotechnology R&D platform company. The business scope covers pharmaceuticals, APIs, biological products, medical devices, cosmetics and health care products, etc. At present, the company has formed a strategic development territory centering on Xi'an headquarter and laying out Guangzhou, Shanghai, Hangzhou and other cities.
At the very beginning, based on the international leading technology in the application of active protein and peptide, HuiKang rised rapidly in bio-skincare raw materials industry in China. It is the first high-tech raw material supplier to advocate the concept of bio-homologous skincare in mainland of China, and also the OEM manufacturer of high-end skincare brands. In 2010, HuiKang marched into biomedical industry comprehensively by adjusting its strategic development plan and launching HuiKang Research Institute with nearly 100 million RMB investment, promoting research in the field of genetic engineering and cell engineering.
At present, HuiKang has a professional R&D team consists of industry elites, well-known university professors, including more than 60 experts backbone. The team has long maintained exchanges and cooperation with overseas biological experts and scholars from Australia and Korea. The R&D center is also the Practice Base of Northwest University and Shaanxi University of Science and Technology. In 2017, the honors of the Xi'an Post-doctoral Innovation Base, Xi'an Talent Work Innovation Experimental Base, and Xi'an Active Protein and Peptides Engineering Center were successively granted to R&D center.
As of September 2021, the company has obtained 115 invention patents, including 102 China invention patents，13 international patents and 74 patents acceptance notices were obtained. There are 2 new drugs of class I and 17 key projects under running, of which 4 have reached international leading level. “Argireline Industeialization Project ” was awarded the Xi’an Science and Technology Progress award, and the research achievements of argireline were published on the cover of American magazine I&EC Research.
HuiKang has obtained plenty of honors, such as China Integrity Management and Service Demonstration Unit, Shaanxi High-tech Enterprises, Shaanxi Quality Credibility AAA Level Enterprise, Shaanxi Industrial Advanced Unit, Shaanxi Private Science and Technology Enterprises, Shaanxi Quality Integrity Recommend Enterprises, Shaanxi Integrity and Social Responsibility Exemplary Unit, Xi’an “Contract&Credit valued” unit, etc.
The company has successively obtained China's integrity management and service demonstration unit, High-tech enterprises in Shaanxi Province, Quality credibility AAA-level enterprises in Shaanxi Province, Advanced industrial unit in Shaanxi Province, Private scientific and technological enterprises in Shaanxi Province, Key quality integrity recommendation enterprises in Shaanxi Province, Integrity and social responsibility model unit in Shaanxi Province, and Xi'an Credit unit and other honors.
In the future, based on the world's leading HuiKang International Peptide Library（China peptide library）project, HuiKang will be committed to become a tip-top producer of biological products, pharmaceutical screening service provider and biological skincare products manufacturer.